Scarica l'app Stockscreener
0.226
5.04%
-0.012
Dopo l'orario di chiusura:
.24
0.014
+6.19%
Precedente Chiudi:
$0.238
Aprire:
$0.243
Volume 24 ore:
595.79K
Relative Volume:
0.05
Capitalizzazione di mercato:
$9.44M
Reddito:
$20.27M
Utile/perdita netta:
$-63.80M
Rapporto P/E:
-0.1487
EPS:
-1.52
Flusso di cassa netto:
$-68.35M
1 W Prestazione:
-5.48%
1M Prestazione:
-41.75%
6M Prestazione:
-44.88%
1 anno Prestazione:
-80.35%
Intervallo 1D:
$0.222
$0.243
Intervallo di 1 settimana:
$0.2146
$0.2443
Portata 52W:
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
Nome
Carisma Therapeutics Inc
Settore
Industria
Telefono
(267) 491-6422
Indirizzo
3675 MARKET STREET, PHILADELPHIA
Confronta CARM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.226 | 9.95M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-04-11 | Iniziato | BTIG Research | Buy |
| 2023-10-03 | Iniziato | CapitalOne | Overweight |
| 2023-07-06 | Iniziato | Evercore ISI | Outperform |
| 2023-05-31 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-05-24 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-14 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Carisma Therapeutics Inc Borsa (CARM) Ultime notizie
Using flow based indicators on Carisma Therapeutics Inc.Product Launch & Safe Entry Zone Tips - Newser
Carisma Therapeutics Inc. Stock Performance After Earnings: Historical Insights2025 Price Momentum & Consistent Growth Stock Picks - Newser
Visual analytics tools that track Carisma Therapeutics Inc. performanceJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Combining price and volume data for Carisma Therapeutics Inc.Earnings Overview Report & Precise Trade Entry Recommendations - Newser
Tick level data insight on Carisma Therapeutics Inc. volatilityJuly 2025 Macro Moves & Low Risk Entry Point Guides - Newser
Has Carisma Therapeutics Inc. formed a bullish divergence2025 Trade Ideas & Daily Profit Focused Stock Screening - Newser
Full technical analysis of Carisma Therapeutics Inc. stockMarket Growth Summary & Stepwise Trade Execution Plans - Newser
Building trade automation scripts for Carisma Therapeutics Inc.Rate Cut & Free Weekly Watchlist of Top Performers - Newser
What earnings revisions data tells us about Carisma Therapeutics Inc.2025 Institutional Moves & Growth Focused Investment Plans - Newser
Chart based analysis of Carisma Therapeutics Inc. trendsPortfolio Risk Report & Reliable Price Action Trade Plans - Newser
Carisma Therapeutics Inc. stock momentum explained2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser
Technical Heatmap Flags Carisma Therapeutics Inc. for Watch2025 Support & Resistance & Growth Focused Stock Reports - beatles.ru
What the charts say about Carisma Therapeutics Inc. todayMarket Activity Recap & Risk Managed Trade Strategies - Newser
Carisma Therapeutics Inc. recovery potential after sell offRisk Management & Weekly Stock Performance Updates - Newser
What to expect from Carisma Therapeutics Inc. in the next 30 days2025 Volume Leaders & AI Driven Stock Movement Reports - Newser
Is it too late to sell Carisma Therapeutics Inc.July 2025 Sector Moves & Short-Term High Return Ideas - Newser
Applying chart zones and confluence areas to Carisma Therapeutics Inc.Market Activity Recap & Daily Technical Forecast Reports - Newser
Will Carisma Therapeutics Inc. continue its uptrend2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
Carisma Therapeutics Inc. stock prediction for this weekQuarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Will Carisma Therapeutics Inc. stock recover after recent dropOil Prices & Low Drawdown Investment Strategies - Newser
Published on: 2025-08-25 21:28:23 - Newser
Bank Watch: Is Carisma Therapeutics Inc. stock overvalued or fairly pricedIndex Update & Weekly Breakout Watchlists - sundaytimes.kr
Has Carisma Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewQuarterly Market Review & Precise Trade Entry Recommendations - Newser
Why Carisma Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Technicals & High Conviction Buy Zone Alerts - Newser
Analyzing net buyer seller activity in Carisma Therapeutics Inc.July 2025 Recap & Capital Efficiency Focused Ideas - Newser
Winners Losers: Can Carisma Therapeutics Inc. ride the EV wavePortfolio Return Report & Verified Trade Idea Suggestions - sundaytimes.kr
Will Carisma Therapeutics Inc. benefit from rate cuts2025 Year in Review & High Accuracy Swing Entry Alerts - sundaytimes.kr
Pattern recognition hints at Carisma Therapeutics Inc. upsideJuly 2025 Pullbacks & Pattern Based Trade Signal System - Newser
What is Carisma Therapeutics Inc. s 5 year growth outlookShort Setup & Risk Managed Investment Entry Signals - theviewers.co.kr
Tech Rally: Is Carisma Therapeutics Inc. still a buy after recent gainsMarket Sentiment Review & Community Verified Watchlist Alerts - baoquankhu1.vn
How Carisma Therapeutics Inc. stock performs during market volatilityJuly 2025 EndofMonth & Free Community Supported Trade Ideas - beatles.ru
Bollinger Band Squeeze Points to Volatility in Carisma Therapeutics Inc.Trade Exit Report & Long-Term Investment Growth Plans - newsyoung.net
Carisma Therapeutics Inc Azioni (CARM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):